Respiratory disorders
17 results
Applied filters
Otigo (phenazone with lidocaine) ear drops for otitis media
1 February 2024SPS PGD template for the supply of Otigo (phenazone with lidocaine) ear drops for symptomatic relief of pain due to otitis media.
Amoxicillin for otitis media
1 February 2024SPS PGD template for the supply of amoxicillin for otitis media.
Doxycycline for sinusitis
18 March 2026SPS PGD template for the supply of doxycycline for sinusitis in penicillin allergy and where an intranasal steroid is unsuitable or ineffective.
Fluticasone furoate nasal spray for sinusitis
25 March 2026SPS PGD template for the supply of fluticasone furoate nasal spray for sinusitis.
Clarithromycin for sore throat
21 April 2026SPS PGD template for the supply of clarithromycin for sore throat in those with a penicillin allergy.
Clarithromycin for otitis media
27 January 2025SPS PGD template for the supply of clarithromycin for otitis media in those with a penicillin allergy.
SMRs in problematic polypharmacy: respiratory focus
13 January 2026Consultant pharmacists used a case study to illustrate a patient centred approach to SMRs for patients with respiratory conditions.
Penicillin V (phenoxymethylpenicillin) for sinusitis
18 March 2026SPS PGD template for the supply of penicillin V (phenoxymethylpenicillin) where an intranasal steroid is unsuitable or ineffective.
Mometasone furoate monohydrate nasal spray for sinusitis
25 March 2026SPS PGD template for the supply of mometasone furorate monohydrate nasal spray for sinusitis.
The licence and supporting evidence for omalizumab biosimilar
20 April 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. Review its indications, evidence, and main differences.